Search Results 111-120 of 17342 for Teratogenic

1. Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin - Mayo Clinic

   ... teratogenic;; Patients must be able to swallow whole tablets. Exclusion Criteria: Definitive clinical or radiologic evidence of distant (beyond cervical ...

2. A Study Testing The Combination Of Dasatinib Or Imatinib To Chemotherapy Treatment With Blinatumomab For Children, Adolescents, And Young Adults With Philadelphia Chromosome Positive (Ph+) Or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL) - Mayo Clinic

   * Female patients who are pregnant since fetal toxicities and teratogenic effects have been noted for several of the study drugs. A negative pregnancy test ...

3. Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia - Mayo Clinic

   ... teratogenic effects on the developing fetus and newborn are unknown: * Pregnant persons * Nursing persons * Persons of childbearing potential who are ...

4. Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma - Mayo Clinic

   Have an understanding that the study drug could have a potential teratogenic risk. Agree to refrain from donating blood while on study treatment, during ...

5. A Study to Test the Addition of berzosertib to Usual Radiation Treatment for Chemotherapy-Resistant Breast Cancer - Mayo Clinic

   For this reason and because DNA-damage repair inhibitors as well as radiation used in this trial are known to be teratogenic, women of child-bearing ...

6. Pilot Clinical Trial Evaluating the Utility of Minocycline as an Agent to Decrease Chemotherapy-Induced Peripheral Neuropathy (CIPN) and Paclitaxel-Induced Acute Pain Syndrome (P-APS): A Randomized Placebo-Controlled, Double Blind Trial - Mayo Clinic

   ... teratogenic effects; Previous diagnosis of diabetic neuropathy or peripheral neuropathy from any cause. History of allergic or other adverse reactions to ...

7. A Study to Determine the Outcomes of Patients With Localized B Cell Lymphoblastic Lymphoma (B-LLy) When Treated With Standard Risk B-ALL Therapy - Mayo Clinic

   - Female patients who are pregnant since fetal toxicities and teratogenic effects have been noted for several of the study drugs. A pregnancy test is ...

8. Blood Brain Barrier Differences in Patients With Brain Tumors Undergoing Surgery - Mayo Clinic

   Note: Pregnant women are excluded from this study because of the potential for teratogenic or abortifacient effects with chemotherapy. There is also a ...

9. Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer - Mayo Clinic

   Women MUST NOT be pregnant or breast-feeding due to the potential teratogenic harm or abortifacient effectsto an unborn fetus and possible risk for adverse ...

10. Publications - Erwin A. Kruger, M.D. - Mayo Clinic

    Synthesis and antiangiogenic activity of the teratogenic and TNFalpha-modulatory thalidomide analogue 2-(2,6-dioxopiperidine-3-yl)phthalimidine. J Med Chem ...